Mergers & Acquisitions ·
On July 10, 2026, SUIC Worldwide Holdings Ltd. completed the acquisition of a 51% controlling interest in Vision Renu…
SUICSUIC Worldwide Holdings Ltd.
On July 10, 2026, SUIC Worldwide Holdings Ltd. completed the acquisition of a 51% controlling interest in Vision Renu Corporation by issuing 30,000,000 shares of common stock valued at $25.5 million based on a closing price of $0.85 per share. The transaction is accounted for as an in-substance reverse recapitalization, resulting in the appointment of Chen King Te as Chairman and CEO, Kho Jean Jean as CFO, and Dongsheng Zou as director, while former executives Harriette Lo, Han Wei Wang, and Yee Wei Tan resigned. Vision Renu focuses on the research, development, and manufacturing of high-tech medical devices, including a scleral micro-ablation laser system for presbyopia and transcranial magnetic stimulation devices for depression treatment. SUIC Worldwide Holdings Ltd. operates in the life sciences and medical technology sector.